Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences
破譯代碼：理解神經分泌生物科學的分析師評論
A clear picture of Neurocrine...Analysts' ratings for Neurocrine Biosciences (NASDAQ:NBIX) over the last quarter vary from bullish to bearish, as provided by 16 analysts.
16位分析師提供的分析師對Neurocrine Biosciences（納斯達克股票代碼：NBIX）在上個季度的評級從看漲到看跌不等。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表簡要介紹了他們最近的收視率，展示了過去30天中不斷變化的情緒，並將其與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $167.94, a high estimate of $216.00, and a low estimate of $138.00. This upward trend is apparent, with the current average reflecting a 5.89% increase from the previous average price target of $158.60.
分析師評估的12個月目標股價揭示了進一步的見解，平均目標價爲167.94美元，最高估計爲216.00美元，低估值爲138.00美元。這種上升趨勢顯而易見，當前的平均價格較之前的平均目標價158.60美元上漲了5.89％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析師評級：全面細分
A clear picture of Neurocrine...
通過對分析...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間